We are live on ! Find out more
PIII icon

P3 Health Partners

16 hedge funds and large institutions have $2M invested in P3 Health Partners in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 5

9.52% more ownership

Funds ownership: 0.21%9.73% (+9.5%)

31% less capital invested

Capital invested by funds: $2.9M → $2M (-$900K)

52% less funds holding

Funds holding: 3316 (-17)

77% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 22

Holders
16
Holders Change
-17
Holders Change %
-51.52%
% of All Funds
0.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
6
Reduced
5
Closed
22
Calls
Puts
Net Calls
Net Calls Change

PIII Hedge Fund Activity: Q2 2025 in Review

16 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in P3 Health Partners (PIII) for Q2 2025, worth a combined $2M — down 31% from $2.9M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of PIII and 5 opened new positions — a net loss of 17 holders — while 5 trimmed existing stakes and 6 added.

The largest buyer was BlackRock, adding an estimated $23K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $66.6K sold.

  • 16 institutional investors held P3 Health Partners (PIII) as of Q2 2025, down from 33 in Q1 2025.
  • Funds reported $2M of P3 Health Partners stock for Q2 2025, down 31% quarter-over-quarter.
  • 5 funds opened new P3 Health Partners positions in Q2 2025 and 22 closed out, a net change of -17 holders.
  • The largest P3 Health Partners buyer in Q2 2025 was BlackRock, an estimated $23K added.
  • The largest P3 Health Partners seller in Q2 2025 was Renaissance Technologies, an estimated $66.6K sold.

Based on aggregated 13F filings for Q2 2025.